Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2020-11-30
2022-03-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability
NCT05920174
Effectiveness of Automated Locomotor Training in Patients With Acute Incomplete Spinal Cord Injury: A Multicenter Trial
NCT01147185
Stimulation With Wire Leads to Restore Cough
NCT01659541
Non-Invasive Stimulation for Improving Motor Function
NCT03592173
Transcutaneous Stimulation for Neurological Populations
NCT04467437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neuromodulation
Neuromodulation
Stimulator
Neuromodulation
Sham
Sham
Sham
Sham
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stimulator
Neuromodulation
Sham
Sham
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Internal metallic objects of unknown or foreign origin
* Implanted anti-spasticity pumps, Botox injections in prior 3 months or other current anti-spasticity regimen
* BMI \> 40.0
* Acute medical conditions under active treatment that would contraindicate standard rehabilitation including open wounds
* Pregnancy or planned pregnancy
* Unhealed bone fractures, peripheral neuropathies or painful musculoskeletal dysfunction
* Cardiopulmonary disease or ventilator dependency
* Uncontrolled epilepsy or seizures
* Clinically significant depression, psychiatric disorders or ongoing substance abuse
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Niche Biomedical, Inc. dba ANEUVO
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shirley Ryan AbilityLab
Chicago, Illinois, United States
Kennedy Krieger Institute
Baltimore, Maryland, United States
Houston Methodist Research Institute
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EXA-2001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.